Replies to post #149248 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Instead, topline typically comes first before publication. You seem to know something about how long this will take ("perhaps many months"), and yet you don’t know. You are guessing. Right now some people have pieced together the impression approximately 233OS data lock, external analysis followed by unblinding. That’s because that is what the company said publicly. Has that changed? Sounds like you think it changed.

You said:

At this stage of the product trial and review, I can assure you that the SEC will be taking a close look at any public communications this company makes. In my experience, company press releases are often "Exhibit A" of shareholder lawsuits.

And your SEC comments seem to be missing the timely issue: The SEC also believe in “timely and full disclosure” of things like “market applications, regulatory status of a clinical research program....”
At least according to A. Ceresney. See article in PharmaExec.com

[GoodGuyBill]

I disagree on several points.

First, you started your statement with "if everything mentioned in those releases occurred as described...". The problem with NWBO is they give us a tidbit of info to collect $$$ from dilutive fundraises and then, after they get their $$$ (and dilute our shares) the go back to ignoring us. We seldom get details about the trial and, therefore, always have to resort to "If...". You indirectly imply that you don't even know if what they presented in the PR is true! No one does, hence the .27 pps.

So was the P3 OS threshold was reached...or not? There are no "deliberate process of review, analysis, review, analysis, and then more review and analysis until conclusions are drawn and papers are written and published" here. If NWBO met the P3 OS threshold, they should say it. If they have not (which would be even better since it would mean no one is dying), they should say it. It isn't complicated. Why should you, a johnny-come-lately (no offence, I welcome you) or a shareholder who is uncompromising in his/her support for 4 years now, not know this when NWBO set the expectation. This is inexcusable!

You believe the end game process involves a very careful, deliberate process of review, analysis, review, analysis, and then more review and analysis until conclusions are drawn and papers are written and published. I agree that the end game requires the company to methodically cross its Ts and dot its Is. But there should be periodic communications with shareholders. Where are the conference calls? When is the ASM?

IMHO, shareholders have given NWBO a blank check to do whatever the want with no accountability/transparency at all. I think the shareholders MUST send a clear message to NWBO: WE HAVE SUPPORTED YOU AND TRUSTED YOU. NOW WE INSIST THAT YOU PROVIDE BASIC, FUNDAMENTAL INFO REGARDING THE P3 TRIAL AND GOVERNANCE TO VALIDATE THAT TRUST AND EARN FURTHER TRUST!

What they wrote in those press releases was accurate, but

if everything mentioned in those releases occurred as described

, then what it means is that right now there is a lot of work going on behind the scenes to bring this product to market. The best way to ensure that happens successfully and without compromise is to operate in quiet mode. Everything that we have staked our hopes for a better world on, and our hard-earned money on, is now at the end game. That end game involves a very careful, deliberate process of review, analysis, review, analysis, and then more review and analysis until conclusions are drawn and papers are written and published. It takes a lot of time – perhaps many months – and any misstep along the way can jeopardize the whole thing. That's why silence is golden right now. When companies make meaningless statements like "the process is ongoing" just to appease a restless audience, it can do serious damage and end up exacerbating the perceived problem. Do you think anyone on this board would be satisfied with that kind of statement? Ha, not likely. And saying anything more than that could be perceived as manipulation. At this stage of the product trial and review, I can assure you that the SEC will be taking a close look at any public communications this company makes. In my experience, company press releases are often "Exhibit A" of shareholder lawsuits. Sure, they can also do good things – inform shareholders and boost share prices – but even the most innocuous-sounding press release carries an inherent risk of backlash, misinterpretation, and/or just plain dissatisfaction from shareholders. I have seen companies send out seemingly mundane and/or routine press releases and have it come back on them in ways they never imagined. Regardless of intent, PR can be very, very dangerous, and right now dangerous is not what NWBO needs. With so much at stake, it's just not worth the risk to be sending out press releases until there is something final and significant to say. I think they are close, but not quite there yet.

[chinatown1980]

The recent massive ownership transfer to LP's private company told us everything we need to know regarding whether or not news is imminent.

My guess, likely nothing in 2018. Probably another billion or so shares will be issued. Unless R/S first, then it would be less shares.